Clinical evaluation of cefpodoxime proxetil in patients with dermatological infections.
Imaizumi
T
T
Department of Dermatology, Hirosaki University School of Medicine, Japan.
Ishikawa
H
H
Hashimoto
I
I
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001419:Bacteria / Q000187:drug effects / Q000302:isolation & purification; D001424:Bacterial Infections / Q000188:drug therapy*; D015296:Ceftizoxime / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D002511:Cephalosporins / Q000627:therapeutic use*; D002648:Child; D005260:Female; D006801:Humans; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D011355:Prodrugs / Q000627:therapeutic use*; D012874:Skin Diseases, Infectious / Q000188:drug therapy*; D000097627:Cefpodoxime Proxetil
D015296:Ceftizoxime; D002511:Cephalosporins; D011355:Prodrugs; D000097627:Cefpodoxime Proxetil